Company Name : Cairo PharmaceuticalsISIN Code : EGS38391C016Reuters Code : CPCI.CAContent : Central Auditing Organization report on the financial statements for the financial period ending 31/03/2025. Central Auditing Organization Report (2,921 KB)
Please be advised that the company's Board of Directors will convene on Thursday, May 14, 2026, in C
The Listing Committee held on 14/05/2026 has approved the following:' Listing the shares of Mi
Copyright © Okaz 2019. Powered by
